Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Managing Care and Cost in a Profit-driven System
-
- Five Important News Items in Pediatric Rheumatology
- AbbVie and Amgen Announce Settlement of Adalimumab Patent Dispute
- FDA Approves First Extended-release Injection to Treat Osteoarthritis Knee Pain
- FDA Approves Shingles Vaccine Shingrix
- Janssen Biotech Receives FDA Approval for Simponi Aria for the Treatment of Active PsA, AS
- Janssen Biotech Will Not Pursue Global Approval for Sirukumab
- Rheumatology, Managed Care and Burnout Leonard H. Calabrese, DO
- Diagnosis and Treatment of Pemphigus Vulgaris: Strategies for Optimal Multidisciplinary Care
-
- Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective Gary S. Hoffman, MD, MS, MACR
- Multidisciplinary Task Force Releases Consensus Document on Biosimilars
- Communication-and-resolution Programs May Avert Lawsuits From Medical Errors
- Extent of Disease Damage Cited as Factor for Higher Mortality Among Impoverished Patients With SLE
- Fatigue, Including Stress, Cited Among the Most Common Triggers of Oral Ulcers for Behcet’s Disease
- Intra-articular Corticosteroid Injections Seen as Efficacious for Short-term Management of Knee OA
- Patients Treated With Febuxostat for Early Gout Had Lower Overall Rate of Flares
- RA Characteristics Responsible for Roughly 30% of CVD Events
-
- Secukinumab Yielded Improvements for PsA Through 2 Years
- Women on Biologics are Likely to Halt These Drugs Once Pregnant
- Association of Women in Rheumatology: Promoting Mentorship, Inclusivity
- Juvenile Arthritis: Treatment is Now a More ‘Optimistic Story’
- California Law May Minimally Impact Drug Pricing Transparency
- Disability Prevention Program Lessened Work Loss Due to Rheumatic, Musculoskeletal Conditions
- Medically Injured Patients Desire to Know More About Prevention Efforts